ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $14,786,000 | +308.1% | 159,095 | +161.5% | 0.00% | – |
| Q3 2021 | $3,623,000 | -42.9% | 60,848 | -34.6% | 0.00% | -100.0% |
| Q2 2021 | $6,340,000 | +863.5% | 92,969 | +880.8% | 0.00% | – |
| Q1 2021 | $658,000 | -86.2% | 9,479 | -84.7% | 0.00% | -100.0% |
| Q4 2020 | $4,771,000 | +70.3% | 62,099 | +65.7% | 0.00% | 0.0% |
| Q3 2020 | $2,802,000 | -2.8% | 37,472 | -18.1% | 0.00% | 0.0% |
| Q2 2020 | $2,882,000 | +109.8% | 45,780 | +39.9% | 0.00% | – |
| Q1 2020 | $1,374,000 | -64.7% | 32,729 | -61.8% | 0.00% | -100.0% |
| Q4 2019 | $3,891,000 | -1.0% | 85,656 | -0.3% | 0.00% | 0.0% |
| Q3 2019 | $3,932,000 | +61.5% | 85,905 | +106.9% | 0.00% | 0.0% |
| Q2 2019 | $2,434,000 | -50.0% | 41,513 | -61.7% | 0.00% | 0.0% |
| Q1 2019 | $4,864,000 | +18.2% | 108,493 | +2.7% | 0.00% | 0.0% |
| Q4 2018 | $4,114,000 | -17.9% | 105,614 | -2.9% | 0.00% | 0.0% |
| Q3 2018 | $5,008,000 | -14.3% | 108,784 | -18.8% | 0.00% | -50.0% |
| Q2 2018 | $5,845,000 | +21.7% | 134,051 | +10.3% | 0.00% | +100.0% |
| Q1 2018 | $4,801,000 | +23.0% | 121,547 | +5.8% | 0.00% | 0.0% |
| Q4 2017 | $3,904,000 | +182.1% | 114,903 | +111.6% | 0.00% | – |
| Q3 2017 | $1,384,000 | +57.1% | 54,307 | +3.9% | 0.00% | – |
| Q2 2017 | $881,000 | – | 52,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |